Pipeline and Programs
Our platform enables rapid and scalable expansion across urgent-care and rescue indications.
Naloxone
Clinical
Opioid poisoning
An easy to use delivery mechanism that requires no patient repositioning. Minimal training, and lower manufacturing costs that can support broader, faster deployment in emergency settings.
Pre-clinical
Epinephrine
Anaphylaxis
Needle-free and pain-free delivery which improves patient compliance. Consistent dosing avoids nasal drip loss and overcomes pediatric nostril size limitations.
Future opportunities
Our delivery platform is designed to support a broad range of acute and episodic indications where speed, reliability, and ease of administration are critical. These include use cases such as seizure management, procedural anxiety, acute migraine, nausea and emesis, pediatric pain and fever, and other time-sensitive interventions where existing oral, injectable, or intranasal delivery methods can limit effectiveness, consistency, or patient compliance.
By addressing fundamental delivery challenges, including variability in absorption, reliance on trained administration, and barriers to use in high-stress or pediatric settings, the platform enables new treatment approaches across urgent-care, emergency, and outpatient environments. Program prioritization and advancement are guided by clinical need, partner interest, and regulatory considerations.